Alkermes
scientific platforms serve as the foundation to strategy and focus in and oncology oncology synaptic dysfunction immune modulation inhibitors agonist engineered alkermes | Alkermes
Company
Deck Type
Deck date
March 2021
Slide
49 of 144
Related slides by other companies
Investor Conference
January 2023
Investor Day
October 2014
Results
February 2023
Results
November 2022
Other recent decks by Alkermes
Investor Conference
January 2024
Results
October 2023
Investor Presentation
October 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2023 Slidebook.io